Matches in Nanopublications for { ?s ?p "[An incremental increase in CCR5 expression was observed for incremental increases in expression of two heparan sulfate genes involved in viral infection, HS3ST3A1 (beta = 0.27, 95% CI = 0.18, 0.35) and HS3ST3B1 (beta = 0.11, 95% CI = 0.06, 0.18).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 8 of
8
with 100 items per page.
- NP650726.RAt8bLj26agBftFAkmvlDORue8__Ji_5XNF43tSBglhOw130_assertion description "[An incremental increase in CCR5 expression was observed for incremental increases in expression of two heparan sulfate genes involved in viral infection, HS3ST3A1 (beta = 0.27, 95% CI = 0.18, 0.35) and HS3ST3B1 (beta = 0.11, 95% CI = 0.06, 0.18).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP650726.RAt8bLj26agBftFAkmvlDORue8__Ji_5XNF43tSBglhOw130_provenance.
- assertion description "[An incremental increase in CCR5 expression was observed for incremental increases in expression of two heparan sulfate genes involved in viral infection, HS3ST3A1 (beta = 0.27, 95% CI = 0.18, 0.35) and HS3ST3B1 (beta = 0.11, 95% CI = 0.06, 0.18).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP386189.RA-IwpcW8bSGV3OXwfe9tnkbXRa-uYgJelGtPpMp3ASlI130_assertion description "[An incremental increase in CCR5 expression was observed for incremental increases in expression of two heparan sulfate genes involved in viral infection, HS3ST3A1 (beta = 0.27, 95% CI = 0.18, 0.35) and HS3ST3B1 (beta = 0.11, 95% CI = 0.06, 0.18).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP386189.RA-IwpcW8bSGV3OXwfe9tnkbXRa-uYgJelGtPpMp3ASlI130_provenance.
- assertion description "[An incremental increase in CCR5 expression was observed for incremental increases in expression of two heparan sulfate genes involved in viral infection, HS3ST3A1 (beta = 0.27, 95% CI = 0.18, 0.35) and HS3ST3B1 (beta = 0.11, 95% CI = 0.06, 0.18).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP794745.RAjBx0lJqkoJIn4WFlOV2pNSk9gzcU1yVJ50dhE6Wg2Jc130_assertion description "[An incremental increase in CCR5 expression was observed for incremental increases in expression of two heparan sulfate genes involved in viral infection, HS3ST3A1 (beta = 0.27, 95% CI = 0.18, 0.35) and HS3ST3B1 (beta = 0.11, 95% CI = 0.06, 0.18).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP794745.RAjBx0lJqkoJIn4WFlOV2pNSk9gzcU1yVJ50dhE6Wg2Jc130_provenance.
- NP794747.RAiN53iuwqTm4tDancNoQYfrSdoiGbuHnscnuGmBKN1ZA130_assertion description "[An incremental increase in CCR5 expression was observed for incremental increases in expression of two heparan sulfate genes involved in viral infection, HS3ST3A1 (beta = 0.27, 95% CI = 0.18, 0.35) and HS3ST3B1 (beta = 0.11, 95% CI = 0.06, 0.18).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP794747.RAiN53iuwqTm4tDancNoQYfrSdoiGbuHnscnuGmBKN1ZA130_provenance.
- NP832979.RAt8-REdPkmQ6qIX01zjZDMwa43q_K1o6cQKffWYA3oPI130_assertion description "[An incremental increase in CCR5 expression was observed for incremental increases in expression of two heparan sulfate genes involved in viral infection, HS3ST3A1 (beta = 0.27, 95% CI = 0.18, 0.35) and HS3ST3B1 (beta = 0.11, 95% CI = 0.06, 0.18).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP832979.RAt8-REdPkmQ6qIX01zjZDMwa43q_K1o6cQKffWYA3oPI130_provenance.
- NP317096.RAxo0tlwIRXchvqamazY5mW9YTrkw3CZ8xAUvXgZZQoOE130_assertion description "[An incremental increase in CCR5 expression was observed for incremental increases in expression of two heparan sulfate genes involved in viral infection, HS3ST3A1 (beta = 0.27, 95% CI = 0.18, 0.35) and HS3ST3B1 (beta = 0.11, 95% CI = 0.06, 0.18).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP317096.RAxo0tlwIRXchvqamazY5mW9YTrkw3CZ8xAUvXgZZQoOE130_provenance.